Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-17299425 in Traumatic Brain Injury
NCT01814982Phase 2Terminated
- Sponsor
- Johnson & Johnson
- Start
- Aug 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of JNJ-17299425 in traumatic brain injury (TBI), sponsored by Johnson & Johnson. Started Aug 2007; status: terminated.
02
Drugs
JNJ-17299425
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01814982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814982.